SCRI Tennessee Oncology Chattanooga — Chattanooga, Tennessee

SCRI Tennessee Oncology Chattanooga is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI Tennessee Oncology Chattanooga has participated in 17 clinical trials.

Therapeutic areas: Colorectal Cancer, Metastatic Breast Cancer, Breast Cancer.

Sponsors: Hoffmann-La Roche, Genentech, Inc., Pfizer.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Tennessee Oncology Chattanooga?

SCRI Tennessee Oncology Chattanooga has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Tennessee Oncology Chattanooga conducted?

SCRI Tennessee Oncology Chattanooga has 17 clinical trials on record. Their work covers Colorectal Cancer, Metastatic Breast Cancer, Breast Cancer.

Is SCRI Tennessee Oncology Chattanooga accredited by Crixeo Health?

Yes — SCRI Tennessee Oncology Chattanooga holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about SCRI Tennessee Oncology Chattanooga?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.